Skip to main content

Table 1 Patient demographics and clinical characteristics

From: Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours

Variable

 

Surveillance group

(N = 56)

No (%)

Age-years

 Median

30

 Standard deviation

8.5

Histology

  Seminoma

27 (48.2)

  Pure EC

10 (19.6)

  Pure Yolk Sac tumor

1 (1.9)

  Mixed tumor

18 (32.1)

Tumor diameter

 ≥4 cm

26 (46.4)

 <4 cm

27 (48.2)

 Unknown

3 (5.4)

Vascular and lymph vessels invasion

 Yes

16 (28.6)

 No

38 (67.8)

 Unknown

2 (3.6)

Presence of EC

 ≥50%

22 (39.2)

 <50%

33 (58.9)

 Unknown

 1 (1.9)

Rete testis invasion

 Yes

18 (32.1)

 No

34 (60.7)

 Unknown

4 (7.1)

Epididymis invasion

 Yes

8 (14.3)

 No

48 (85.7)

 Unknown

0 (0)

Stage

 IA

27 (48.2)

 IB

11 (19.6)

 IS

17 (30.3)

Unknown

1 (1.9)

  1. EC embryonal carcinoma